Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss Navient Corporation JSM Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Operational Signals DRCT Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines Amid Revenue Uncertainty FNLC Q1 2026 Earnings EPS of 080 Reported Stock Edges Up Amid Sparse Disclosure UUUU Q1 2026 Earnings NarrowerThanExpected Loss Amid Uranium Market Strength BMY Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline and Pipeline Advances Texas Instruments Q1 2026 Earnings Strong EPS Beat Drives Stock Higher COLD Q1 2026 Earnings EPS Surprises to the Upside as Loss Narrows FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported ACEL Q1 2026 Earnings EPS Surges Past Estimates by 5477 Amid Operational Strength CVNA Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Central Garden Pet CENT Q1 2026 Earnings Strong EPS Beat of 154 Drives Modest Stock Gains